J Physiol Wellcome Trust-funded researchers
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


J Physiol Volume 586, Number 2, 639-647, January 15, 2008 DOI: 10.1113/jphysiol.2007.143180
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Erratum (v586,p1777)
Right arrow All Versions of this Article:
586/2/639    most recent
jphysiol.2007.143180v1
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Burgess, H. J.
Right arrow Articles by Eastman, C. I.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Burgess, H. J.
Right arrow Articles by Eastman, C. I.
Related Collections
Right arrow Renal and Endocrine

RENAL AND ENDOCRINE

A three pulse phase response curve to three milligrams of melatonin in humans

Helen J. Burgess1, Victoria L. Revell2 and Charmane I. Eastman1

1 Biological Rhythms Research Laboratory, Department of Behavioural Sciences, Rush University Medical Center, Chicago, IL, USA
2 Faculty of Health and Medical Sciences, University of Surrey, Guildford, Surrey GU2 7XH, UK

Exogenous melatonin is increasingly used for its phase shifting and soporific effects. We generated a three pulse phase response curve (PRC) to exogenous melatonin (3 mg) by administering it to free-running subjects. Young healthy subjects (n = 27) participated in two 5 day laboratory sessions, each preceded by at least a week of habitual, but fixed sleep. Each 5 day laboratory session started and ended with a phase assessment to measure the circadian rhythm of endogenous melatonin in dim light using 30 min saliva samples. In between were three days in an ultradian dim light (< 150 lux)–dark cycle (LD 2.5 : 1.5) during which each subject took one pill per day at the same clock time (3 mg melatonin or placebo, double blind, counterbalanced). Each individual's phase shift to exogenous melatonin was corrected by subtracting their phase shift to placebo (a free-run). The resulting PRC has a phase advance portion peaking about 5 h before the dim light melatonin onset, in the afternoon. The phase delay portion peaks about 11 h after the dim light melatonin onset, shortly after the usual time of morning awakening. A dead zone of minimal phase shifts occurred around the first half of habitual sleep. The fitted maximum advance and delay shifts were 1.8 h and 1.3 h, respectively. This new PRC will aid in determining the optimal time to administer exogenous melatonin to achieve desired phase shifts and demonstrates that using exogenous melatonin as a sleep aid at night has minimal phase shifting effects.

(Received 16 August 2007; accepted after revision 9 November 2007; first published online 15 November 2007)
Corresponding author H. J. Burgess: Biological Rhythms Research Laboratory, Rush University Medical Center, 1645 W. Jackson Blvd, Suite 425, Chicago, IL 60612, USA. Email: helen_j_burgess{at}rush.edu




This article has been cited by other articles:


Home page
J. Physiol.Home page
Erratum
J. Physiol., March 15, 2008; 586(6): 1777 - 1777.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2008 The Physiological Society.